Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Haferkamp

Showing results (21-30 of 149) with videos related to

Pageof 15
Sort By:
Life (Basel, Switzerland)|March 29, 2023
Degree of Actinic Elastosis Is a Surrogate of Exposure to Chronic Ultraviolet Radiation and Correlates More Strongly with Cutaneous Squamous Cell Carcinoma than Basal Cell CarcinomaKonstantin Drexler, Hans Drexler, Sigrid Karrer, et al.
Cancers|January 11, 2024
Subtypes of Melanomas Associated with Different Degrees of Actinic Elastosis in Conventional Histology, Irrespective of Age and Body Site, Suggesting Chronic Ultraviolet Light Exposure as Driver for Lentigo Maligna Melanoma and Nodular MelanomaKonstantin Drexler, Veronika Zenderowski, Laura Schreieder, et al.
Aging|February 17, 2010
The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescenceSebastian Haferkamp, Sieu L Tran, Therese M Becker, et al.
Pharmaceutics|May 27, 2026
Boosting the Activity of Melanoma-Targeting CAR-T Cells in the Presence of Citrate by the Application of GluconateDennis Christoph Harrer, Sebastian Haferkamp, Wolfgang Herr, et al.
British Journal of Cancer|June 1, 2021
Association between physical activity, grip strength and sedentary behaviour with incidence of malignant melanoma: results from the UK BiobankAndrea Weber, Michael F Leitzmann, Anja M Sedlmeier, et al.
Cancer Immunology, Immunotherapy : CII|January 13, 2021
Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinomaValerie Glutsch, Hermann Kneitz, Anja Gesierich, et al.
Cancer Letters|November 28, 2018
Metabolic targeting synergizes with MAPK inhibition and delays drug resistance in melanomaChristina Brummer, Stephanie Faerber, Christina Bruss, et al.
Cancers|July 27, 2022
The Role of Citrate Homeostasis in Merkel Cell Carcinoma PathogenesisKonstantin Drexler, Barbara Schwertner, Silke Haerteis, et al.
Cancer Letters|March 23, 2016
Combination with γ-secretase inhibitor prolongs treatment efficacy of BRAF inhibitor in BRAF-mutated melanoma cellsGuannan Zhu, Xiuli Yi, Sebastian Haferkamp, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|March 15, 2024
Complete lymph node dissection in cutaneous melanoma patients with positive sentinel lymph node: Outcome and predictors in a retrospective cohort study over 16 yearsHelena Baecher, Michael Gerken, Leonard Knoedler, et al.
Pageof 15

Showing results (21-30 of 149) with videos related to

Sort By:
Pageof 15
Life (Basel, Switzerland)|March 29, 2023
Degree of Actinic Elastosis Is a Surrogate of Exposure to Chronic Ultraviolet Radiation and Correlates More Strongly with Cutaneous Squamous Cell Carcinoma than Basal Cell CarcinomaKonstantin Drexler, Hans Drexler, Sigrid Karrer, et al.
Cancers|January 11, 2024
Subtypes of Melanomas Associated with Different Degrees of Actinic Elastosis in Conventional Histology, Irrespective of Age and Body Site, Suggesting Chronic Ultraviolet Light Exposure as Driver for Lentigo Maligna Melanoma and Nodular MelanomaKonstantin Drexler, Veronika Zenderowski, Laura Schreieder, et al.
Aging|February 17, 2010
The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescenceSebastian Haferkamp, Sieu L Tran, Therese M Becker, et al.
Pharmaceutics|May 27, 2026
Boosting the Activity of Melanoma-Targeting CAR-T Cells in the Presence of Citrate by the Application of GluconateDennis Christoph Harrer, Sebastian Haferkamp, Wolfgang Herr, et al.
British Journal of Cancer|June 1, 2021
Association between physical activity, grip strength and sedentary behaviour with incidence of malignant melanoma: results from the UK BiobankAndrea Weber, Michael F Leitzmann, Anja M Sedlmeier, et al.
Cancer Immunology, Immunotherapy : CII|January 13, 2021
Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinomaValerie Glutsch, Hermann Kneitz, Anja Gesierich, et al.
Cancer Letters|November 28, 2018
Metabolic targeting synergizes with MAPK inhibition and delays drug resistance in melanomaChristina Brummer, Stephanie Faerber, Christina Bruss, et al.
Cancers|July 27, 2022
The Role of Citrate Homeostasis in Merkel Cell Carcinoma PathogenesisKonstantin Drexler, Barbara Schwertner, Silke Haerteis, et al.
Cancer Letters|March 23, 2016
Combination with γ-secretase inhibitor prolongs treatment efficacy of BRAF inhibitor in BRAF-mutated melanoma cellsGuannan Zhu, Xiuli Yi, Sebastian Haferkamp, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|March 15, 2024
Complete lymph node dissection in cutaneous melanoma patients with positive sentinel lymph node: Outcome and predictors in a retrospective cohort study over 16 yearsHelena Baecher, Michael Gerken, Leonard Knoedler, et al.
Pageof 15